Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
JE Ebinger, J Fert-Bober, I Printsev, M Wu, N Sun… - Nature medicine, 2021 - nature.com
In a cohort of BNT162b2 (Pfizer–BioNTech) mRNA vaccine recipients (n= 1,090), we
observed that spike-specific IgG antibody levels and ACE2 antibody binding inhibition …
observed that spike-specific IgG antibody levels and ACE2 antibody binding inhibition …
Awareness of SARS-CoV-2 Omicron variant infection among adults with recent COVID-19 seropositivity
SY Joung, JE Ebinger, N Sun, Y Liu, M Wu… - JAMA Network …, 2022 - jamanetwork.com
Importance Some individuals who were infected by the SARS-CoV-2 Omicron variant may
have been completely unaware of their infectious status while the virus was actively …
have been completely unaware of their infectious status while the virus was actively …
Paradoxical sex-specific patterns of autoantibody response to SARS-CoV-2 infection
Y Liu, JE Ebinger, R Mostafa, P Budde… - Journal of Translational …, 2021 - Springer
Background Pronounced sex differences in the susceptibility and response to SARS-CoV-2
infection remain poorly understood. Emerging evidence has highlighted the potential …
infection remain poorly understood. Emerging evidence has highlighted the potential …
Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK)
Background Prospective population-based studies investigating multiple determinants of pre-
vaccination antibody responses to SARS-CoV-2 are lacking. Methods We did a prospective …
vaccination antibody responses to SARS-CoV-2 are lacking. Methods We did a prospective …
Sustained seropositivity up to 20.5 months after COVID-19
This study evaluated the persistence of IgM, IgA, and IgG to SARS-CoV-2 spike and
nucleocapsid antigens up to 616 days since the onset of symptoms in a longitudinal cohort …
nucleocapsid antigens up to 616 days since the onset of symptoms in a longitudinal cohort …
[HTML][HTML] Prior COVID-19 infection and antibody response to single versus double dose mRNA SARS-CoV-2 vaccination
JE Ebinger, J Fert-Bober, I Printsev, M Wu, N Sun… - MedRxiv, 2021 - ncbi.nlm.nih.gov
The double dose regimen for mRNA vaccines against SARS-CoV-2 presents both a hope
and a challenge for global efforts to curb the COVID-19 pandemic. With supply chain …
and a challenge for global efforts to curb the COVID-19 pandemic. With supply chain …
SARS-CoV-2 seroprevalence around the world: an updated systematic review and meta-analysis
Background Covid-19 has been one of the major concerns around the world in the last 2
years. One of the challenges of this disease has been to determine its prevalence …
years. One of the challenges of this disease has been to determine its prevalence …
Serological response to vaccination in post-acute sequelae of COVID
Background Individuals with post-acute sequelae of COVID (PASC) may have a persistence
in immune activation that differentiates them from individuals who have recovered from …
in immune activation that differentiates them from individuals who have recovered from …
BIRCH: an automated workflow for evaluation, correction, and visualization of batch effect in bottom-up mass spectrometry-based proteomics data
N Sundararaman, A Bhat, V Venkatraman… - Journal of proteome …, 2023 - ACS Publications
Recent surges in large-scale mass spectrometry (MS)-based proteomics studies demand a
concurrent rise in methods to facilitate reliable and reproducible data analysis …
concurrent rise in methods to facilitate reliable and reproducible data analysis …
Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an …
Objectives We sought to understand the demographic and clinical factors associated with
variations in longitudinal antibody response following completion of two-dose regiment of …
variations in longitudinal antibody response following completion of two-dose regiment of …